Friday, September 29, 2023


Biotechnology News Magazine

Industry Expert Articles

How Biotech Businesses Can Benefit from Freelance Experts

Ashmita Das, CEO of open talent platform Kolabtree, shares some of Kolabtree freelancer’s success stories.

Modernization of Clinical Trials Amidst the Pandemic

This article, written by Kolabtree's freelance scientist Aditi Kandlur, elaborates on how the pandemic has brought about an evolution in clinical trials.

The Pros and Cons of Personalized Medicine By Dr. Pierre Eftekhari, CEO of Inoviem Scientific & Bcell Design

Dr. Pierre Eftekhari, CEO of Inoviem Scientific & Bcell Design, weighs in on the promise of personalized medicine.

Strategies to Keep Pace Amid Rapid Changes in Drug Development – By Jeff Souza, President and CEO of BioBridges

Pharmaceutical companies are weathering rapid changes in drug development driven by upstream issues, downstream issues, and recently, the management and acceleration of programs during a worldwide pandemic. Read on.

The Promise & Pressures of Biologics R&D By Christian Olsen, Dotmatics

Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel treatments quickly and cost-effectively.

The Promise of a Scientific Informatics Platform: By Michael Swartz, SVP Enterprise Product Strategy at Dotmatics

The promise of a platform is to enable global collaboration, workflow support, consistent regulatory compliance, and optimal decision making. There is an underlying assumption that “one platform” will enable these things. But how, and what is it precisely? Read on to learn more.